Detalhe da pesquisa
1.
Organoid cultures derived from patients with advanced prostate cancer.
Cell
; 159(1): 176-187, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201530
2.
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
Mol Ther
; 31(3): 801-809, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518078
3.
Immunotherapy combinations for metastatic castration-resistant prostate cancer - failed trials and future aspects.
Curr Opin Urol
; 33(5): 390-395, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395505
4.
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Circulation
; 144(16): 1295-1307, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459214
5.
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Prostate
; 82(11): 1107-1116, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538298
6.
American Cancer Society prostate cancer survivorship care guidelines.
CA Cancer J Clin
; 64(4): 225-49, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916760
7.
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV.
Can J Urol
; 27(5): 10352-10362, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33049187
8.
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.
Cancer
; 125(4): 524-532, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427533
9.
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).
J Urol
; 201(4): 682-692, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30077557
10.
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.
Invest New Drugs
; 37(5): 1052-1060, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725389
11.
Sipuleucel-T: When and for Whom to Recommend It.
Oncology (Williston Park)
; 31(12): 900-1, 910-2, 2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297175
12.
Immunotherapy for prostate cancer: is prostate an immune responsive tumor?
Curr Opin Urol
; 26(6): 529-34, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533500
13.
Immunotherapy in metastatic prostate cancer.
Indian J Urol
; 32(4): 271-276, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843208
14.
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Int J Cancer
; 136(1): 127-37, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832153
15.
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
Cancer
; 121(21): 3853-61, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26178426
16.
Repetitively dosed docetaxel and ¹5³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.
Cancer
; 119(17): 3186-94, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23765638
17.
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.
Eur J Nucl Med Mol Imaging
; 40(9): 1384-93, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653243
18.
Genomic Portraits: Reflections into a Tumor's Response to Therapy.
Clin Cancer Res
; 29(21): 4323-4325, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646769
19.
An AI Predictive Model to Determine Who Benefits from ADT with Radiation: Working Smarter, Not Harder.
NEJM Evid
; 2(8): EVIDe2300146, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320151
20.
Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 41(32): 5015-5024, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582240